CVRx (CVRX) Liabilities and Shareholders Equity (2020 - 2026)
CVRx's quarterly Liabilities and Shareholders Equity came in at $99.7 million in Q1 2026, down 23.04% year-on-year from $129.6 million in Q1 2025, and down 4.83% quarter-over-quarter from $104.8 million in Q4 2025.
CVRx has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $99.7 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 23.04% year-over-year to $99.7 million; the trailing twelve-month figure through Mar 2026 stood at $435.4 million (down 10.53% YoY), and the FY2025 full-year result was $104.8 million, down 21.45% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $99.7 million, down from $104.8 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $144.4 million in Q1 2022, with the low at $96.0 million in Q2 2024.
- Average Liabilities and Shareholders Equity over 5 years is $118.7 million, with a median of $119.6 million recorded in 2025.
- Peak annual rise in Liabilities and Shareholders Equity reached 143.43% in 2022, while the deepest fall reached 30.34% in 2022.
- Tracing CVRX's Liabilities and Shareholders Equity over 5 years: stood at $124.9 million in 2022, then decreased by 7.77% to $115.2 million in 2023, then increased by 15.78% to $133.4 million in 2024, then dropped by 21.45% to $104.8 million in 2025, then decreased by 4.83% to $99.7 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $99.7 million (Q1 2026), $104.8 million (Q4 2025), and $111.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | 99.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.73 Mn |
| Dec 31, 2025 | 104.79 Mn |
| Sep 30, 2025 | 111.33 Mn |
| Jun 30, 2025 | 119.56 Mn |
| Mar 31, 2025 | 129.59 Mn |
| Dec 31, 2024 | 133.41 Mn |
| Sep 30, 2024 | 127.67 Mn |
| Jun 30, 2024 | 95.98 Mn |
| Mar 31, 2024 | 106.17 Mn |
| Dec 31, 2023 | 115.23 Mn |
| Sep 30, 2023 | 106.40 Mn |
| Jun 30, 2023 | 114.97 Mn |
| Mar 31, 2023 | 122.69 Mn |
| Dec 31, 2022 | 124.94 Mn |
| Sep 30, 2022 | 126.58 Mn |
| Jun 30, 2022 | 134.04 Mn |
| Mar 31, 2022 | 144.41 Mn |
| Dec 31, 2021 | 152.55 Mn |
| Sep 30, 2021 | 181.71 Mn |
| Jun 30, 2021 | 55.06 Mn |
| Dec 31, 2020 | 64.78 Mn |